Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Niger J Clin Pract ; 25(12): 2016-2023, 2022 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-36537460

RESUMO

Aim: The primary aim of this study was to determine the risk factors for the occurrence of brachial plexus injury in cases of shoulder dystocia. Secondly, it was aimed to determine the factors affecting the occurrence of permanent sequelae in cases with brachial plexus injury. Subjects and Methods: ICD-10 codes were scanned from the records of patients who gave birth between 2012 and 2018, and the records of patients with brachial plexus injury and shoulder dystocia were reached. Shoulder dystocia cases with brachial plexus damage were accepted as the study group, and shoulder dystocia cases without brachial plexus damage were considered the control group. Shoulder dystocia patients with brachial plexus injury and without injury were compared for 2-year orthopedics clinic follow-up reports, surgical intervention, permanent sequelae status as well as birth data, maternal characteristics, and maneuvers applied to the management of shoulder dystocia. Results: Five hundred sixty births with shoulder dystocia were detected. Brachial plexus injury was observed in 88 of them, and permanent sequelae were detected in 12 of these patients. Maneuvers other than McRobert's (advanced maneuvers) were used more and clavicle fracture was seen more in the group with plexus injury (P < 0.05, P < 0.05, respectively). Logistic regression analysis was performed to determine the risk factors of brachial plexus injury. Brachial plexus injury was observed 4.746 times more in infants who were delivered with advanced maneuvers and 3.58 times more in infants with clavicle fractures at birth. Conclusion: In patients with shoulder dystocia, the risk of brachial plexus injury increased in deliveries in which advanced maneuvers were used and clavicle fracture occurred.


Assuntos
Plexo Braquial , Distocia , Fraturas Ósseas , Distocia do Ombro , Gravidez , Recém-Nascido , Feminino , Humanos , Parto Obstétrico , Distocia/epidemiologia , Distocia/etiologia , Plexo Braquial/lesões , Fraturas Ósseas/epidemiologia , Progressão da Doença , Fatores de Risco
2.
J Pediatr Endocrinol Metab ; 14(6): 807-10, 2001 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-11453534

RESUMO

Cohen syndrome is a rare genetic disorder consisting of truncal obesity, hypotonia, mental retardation, microcephalia, characteristic facial appearance and ocular anomalies. Other diagnostic clinical features include narrow hands and feet, low growth parameters, neutropenia and chorioretinal dystrophy. Acanthosis nigricans is a cutaneous disorder characterized by hyperpigmentation and papillomatosis. Syndromal acanthosis nigricans may occasionally appear as a feature of several specific syndromes. We report a patient showing the typical characteristics of Cohen syndrome with acanthosis nigricans and hyperinsulinemia.


Assuntos
Acantose Nigricans/complicações , Anormalidades do Olho/complicações , Resistência à Insulina , Deficiência Intelectual/complicações , Microcefalia/complicações , Hipotonia Muscular/complicações , Obesidade/complicações , Criança , Feminino , Humanos , Síndrome
3.
Adv Perit Dial ; 15: 273-7, 1999.
Artigo em Inglês | MEDLINE | ID: mdl-10682117

RESUMO

The effects of recombinant human erythropoietin (rHuEPO) on plasma and peritoneal effluent levels of antithrombin III (AT-III), protein C (PC) activity, and protein S (PS) activity were evaluated in 10 uremic children on continuous ambulatory peritoneal dialysis (CAPD). The findings were compared with values obtained from ten healthy children. Levels of AT-III and of PC and PS activity in plasma and peritoneal effluent were measured before, and at 8 and 12 weeks after, rHuEPO treatment. Baseline levels of AT-III and PC activity in plasma were lower than the control values. Levels of PC activity increased during the trial, while levels of AT-III remained unchanged, and levels of PS activity decreased. Baseline levels of PC activity in peritoneal effluent were lower than those obtained during rHuEPO treatment, while no change in peritoneal levels of PS activity and AT-III was observed after rHuEPO treatment. A significant positive correlation was seen between plasma and peritoneal levels of PC activity at baseline. A significant positive correlation was also seen between plasma levels of PS activity and hemoglobin at week 12, and a significant negative correlation between plasma levels of AT-III and albumin at week 8. No correlation was found between the plasma natural coagulation inhibitors and CAPD duration. These results suggest that plasma PS activity can be decreased, and plasma PC activity increased, by rHuEPO treatment in children.


Assuntos
Antitrombina III/análise , Eritropoetina/farmacologia , Diálise Peritoneal Ambulatorial Contínua , Proteína C/análise , Proteína S/análise , Adolescente , Adulto , Anemia/prevenção & controle , Criança , Pré-Escolar , Feminino , Humanos , Masculino , Proteínas Recombinantes
5.
J Biomater Sci Polym Ed ; 12(3): 283-96, 2001.
Artigo em Inglês | MEDLINE | ID: mdl-11484937

RESUMO

In this study, DNA binding properties of poly(ethylenimine) (PEI)-attached uniform poly(p-chloromethystyrene) (PCMS) particles were investigated. Spherical PCMS latex particles with an average size of 1.75 microm were obtained by the dispersion polymerization of p-chloromethylstyrene (CMS). PEI was covalently attached onto the PCMS particles via a direct chemical reaction between amine and chloromethyl groups, with the equilibrium binding capacities up to 41 mg PEI/g PCMS. In aqueous media, PEI attached-uniform PCMS particles showed an irreversible aggregation behaviour in the presence of DNA. To predict unknown DNA concentration, the aggregation response of these particles to the presence of DNA was quantified by spectrophotometry. Plain PCMS and PEI attached-uniform PCMS particles were also utilized as sorbents in DNA adsorption experiments conducted at +4 degrees C in a phosphate buffer medium at pH 7.4. DNA immobilization capacities up to 45 mg DNA/g PCMS could be achieved with the PEI attached particles.


Assuntos
DNA/metabolismo , Látex/química , Poliestirenos/química , Adsorção , Animais , DNA/análise , Relação Dose-Resposta a Droga , Terapia Genética/métodos , Concentração de Íons de Hidrogênio , Ligantes , Microscopia Eletrônica de Varredura , Modelos Estatísticos , Polietilenoimina/química , Salmão , Temperatura
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA